Skip to main content
. 2020 Mar 6;7(1):59–67. doi: 10.1093/ehjqcco/qcaa016

Figure 2.

Figure 2

Achievement of an LDL-C level of <1.8 mmol/L and a ≥50% reduction in LDL-C level and lipid-lowering therapies at 6–10 weeks and 12–14 months after myocardial infarction for the total study period and for follow-up visits occurring before and after the release of the 2016 ESC/EAS guidelines. ESC, European Society of Cardiology; EAS, European Atherosclerosis Society; LDL-C, low-density lipoprotein cholesterol.